Google DeepMind's AlphaGenome 2 maps DNA changes to cellular disease roots
Audio narration · Coming soon
Google DeepMind has introduced AlphaGenome 2, an advanced AI model aimed at understanding how DNA variations impact different cell types. This development offers researchers a more detailed perspective on the cellular origins of diseases, potentially guiding future treatment strategies. The announcement marks a significant step in applying AI to complex genetic research.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by theverge